Zobrazeno 1 - 10
of 40
pro vyhledávání: '"David R. Wise"'
Autor:
Jonathan W. Lischalk, Astrid Sanchez, Vianca F. Santos, Christopher Mendez, Meredith Akerman, Todd Carpenter, Moses Tam, David Byun, David R. Wise, Anand Mahadevan, Andrew Evans, William Huang, Aaron Katz, Herbert Lepor, Jonathan A. Haas
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Purpose Percentage of positive cores involved on a systemic prostate biopsy has been established as a risk factor for adverse oncologic outcomes and is a National Comprehensive Cancer Network (NCCN) independent parameter for unfavorable inte
Externí odkaz:
https://doaj.org/article/69a4c08dda084336b03e554e47f0f36a
Autor:
Neal Shore, Christopher Pieczonka, Mukaram Gazi, Sean Heron, David Cahn, Laurence Belkoff, Aaron Berger, Brian Mazzarella, Joseph Veys, David Morris, Alexander Engelman, Paul Dato, Richard Bevan-Thomas, Kathryn Hatchell, Robert Cornell, David R. Wise, Brandie Heald, Sarah Nielsen (Young), Robert Nussbaum, Edward Esplin
Publikováno v:
Genetics in Medicine Open, Vol 1, Iss 1, Pp 100056- (2023)
Externí odkaz:
https://doaj.org/article/79ab8d4d2e8e4fd6a82e1ce5ad8c7c32
Translating the Immunobiology of SBRT to Novel Therapeutic Combinations for Advanced Prostate Cancer
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Stereotactic body radiotherapy (SBRT) is an increasingly used radiation modality for the treatment of both localized and metastatic prostate cancer. Substantial data suggests that prostate cancer may be more sensitive to higher doses of radiation per
Externí odkaz:
https://doaj.org/article/136f64015d9b4a45be6a2fa39a51f79a
Autor:
Stacy Loeb, Nataliya Byrne, Dawn Walter, Danil V. Makarov, David R. Wise, Daniel Becker, Veda N. Giri
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100212- (2020)
Background: Germline testing is recommended for all men with metastatic prostate cancer (PCa), and for some with localized PCa meeting specific histologic or family history criteria. Germline genetic evaluation has important implications for PCa prog
Externí odkaz:
https://doaj.org/article/5f9c66a3d4274c5cad550dea92133bed
Autor:
Victor R. Adorno Febles, Yuan Hao, Aarif Ahsan, Jiansheng Wu, Yingzhi Qian, Hua Zhong, Stacy Loeb, Danil V. Makarov, Herbert Lepor, James Wysock, Samir S. Taneja, William C. Huang, Daniel J. Becker, Arjun V. Balar, Jonathan Melamed, Fang‐Ming Deng, Qinghu Ren, Donald Kufe, Kwok‐Kin Wong, Dennis O. Adeegbe, Jiehui Deng, David R. Wise
Publikováno v:
The Prostate. 83:840-849
Autor:
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, Luis Pina, Jessica E Hawley, Emily Lin, Benjamin A Gartrell, Victor Adorno Febles, David R Wise, Qian Qin, George Mellgard, Himanshu Joshi, Jones T Nauseef, David A Green, Panagiotis J Vlachostergios, Daniel H Kwon, Franklin Huang, Bobby Liaw, Scott Tagawa, Philip Kantoff, Michael J Morris, William K Oh
Publikováno v:
JNCI cancer spectrum, vol 6, iss 3
Background TMPRSS2, a cell surface protease regulated by androgens and commonly upregulated in prostate cancer (PCa), is a necessary component for SARS-CoV-2 viral entry into respiratory epithelial cells. Previous reports suggested a lower risk of SA
Autor:
Justine Habault, Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, Joseph Puccini, Dafna Bar-Sagi, Kwok-Kin Wong, Amina Zoubeidi, Frank Claessens, David R. Wise, Susan K. Logan, Kent Kirshenbaum, Michael J. Garabedian
Publikováno v:
Cancer Research. 83:3441-3441
Prostate cancers adapt to androgen receptor (AR) pathway inhibitors and progress to castration resistance despite the continued expression and function of the AR. We developed a new approach to antagonize the proliferative activity of AR and inhibit
Autor:
Minas P. Economides, Jonathan Lee, Xiaochun Li, Mari Nakazawa, Lucas Hollifield, Michal Sarfaty, Judith D. Goldberg, Emmanuel S. Antonarakis, David R Wise
Publikováno v:
Journal of Clinical Oncology. 41:139-139
139 Background: The germline I1307K mutation in the adenomatous polyposis coli (APC) gene is a well-known alteration identified in approximately 6% of the Ashkenazi Jewish population. This mutation confers an increased risk of developing colorectal a
Autor:
Mark N. Stein, Jingsong Zhang, William Kevin Kelly, David R Wise, Kai Tsao, Benedito A. Carneiro, Gerald Steven Falchook, Furong Sun, Shilpa Govindraj, Jennifer S Sims, Min Zhu, Frank A. Seebach, Israel Lowy, Pradeep Thanigaimani, Sabina Sandigursky, Elizabeth Miller
Publikováno v:
Journal of Clinical Oncology. 41:154-154
154 Background: Pts with mCRPC have a poor prognosis with limited treatment options, including minimal response to immunotherapies. REGN5678 is a first-in-class, full-length anti-PSMAxCD28 bispecific costimulatory antibody designed to target prostate
Autor:
Niven Mehra, Debbie Robbrecht, Jens Voortman, Paul WHI Parren, Sonia Macia, Jorden Veeneman, Sanjana Umarale, Benjamin Winograd, Hans J. van der Vliet, David R Wise
Publikováno v:
Journal of Clinical Oncology. 41:153-153
153 Background: LAVA-1207 is a humanized bispecific antibody of 78 kDa comprised of two single domain antibody (VHH) fragments linked to a silenced fragment crystallizable immunoglobulin region. As shown pre-clinically, LAVA-1207 binds with high affi